BROMOCRIPTINE MESYLATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Bromocriptine Mesylate, and when can generic versions of Bromocriptine Mesylate launch?
Bromocriptine Mesylate is a drug marketed by Lek Pharm, Mylan, Zydus Pharms Usa Inc, Aurobindo Pharma Usa, Padagis Us, and Sandoz. and is included in six NDAs.
The generic ingredient in BROMOCRIPTINE MESYLATE is bromocriptine mesylate. There are nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the bromocriptine mesylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Bromocriptine Mesylate
A generic version of BROMOCRIPTINE MESYLATE was approved as bromocriptine mesylate by SANDOZ on January 13th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BROMOCRIPTINE MESYLATE?
- What are the global sales for BROMOCRIPTINE MESYLATE?
- What is Average Wholesale Price for BROMOCRIPTINE MESYLATE?
Summary for BROMOCRIPTINE MESYLATE
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 6 |
| Finished Product Suppliers / Packagers: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 53 |
| Clinical Trials: | 6 |
| Drug Prices: | Drug price information for BROMOCRIPTINE MESYLATE |
| What excipients (inactive ingredients) are in BROMOCRIPTINE MESYLATE? | BROMOCRIPTINE MESYLATE excipients list |
| DailyMed Link: | BROMOCRIPTINE MESYLATE at DailyMed |
Recent Clinical Trials for BROMOCRIPTINE MESYLATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Andrew Moshfeghi, MD, MBA | Phase 1/Phase 2 |
| Case Western Reserve University | Phase 1/Phase 2 |
| VeroScience | Phase 1 |
Pharmacology for BROMOCRIPTINE MESYLATE
| Drug Class | Ergot Derivative |
Medical Subject Heading (MeSH) Categories for BROMOCRIPTINE MESYLATE
Anatomical Therapeutic Chemical (ATC) Classes for BROMOCRIPTINE MESYLATE
US Patents and Regulatory Information for BROMOCRIPTINE MESYLATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lek Pharm | BROMOCRIPTINE MESYLATE | bromocriptine mesylate | CAPSULE;ORAL | 075100-001 | Dec 10, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Aurobindo Pharma Usa | BROMOCRIPTINE MESYLATE | bromocriptine mesylate | TABLET;ORAL | 076962-001 | Sep 24, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mylan | BROMOCRIPTINE MESYLATE | bromocriptine mesylate | CAPSULE;ORAL | 077226-001 | Apr 4, 2005 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
